PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate diagnostic imaging techniques using 124I-NM404
PET/CT in human brain tumors. This goal will be accomplished by quantifying tumor uptake and
determining the optimal PET/CT protocol, comparing PET tumor uptake to MRI, and calculating
tumor dosimetry. The long-term goals of this research are to improve the diagnosis and
treatment of malignant brain tumors by using radioiodinated NM404